{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:08:41Z","timestamp":1772212121578,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Functional Genomics Center","award":["W81XWH-08-2-0101"],"award-info":[{"award-number":["W81XWH-08-2-0101"]}]},{"name":"National Functional Genomics Center","award":["W81XWH-08-2-0101"],"award-info":[{"award-number":["W81XWH-08-2-0101"]}]},{"name":"Tissue Core and the Biostatistics and Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center & Research Institute","award":["P30-CA076292"],"award-info":[{"award-number":["P30-CA076292"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Loss of stromal caveolin-1 (Cav-1) is a biomarker of a cancer-associated fibroblast (CAF) phenotype and is related to progression, metastasis, and poor outcomes in several cancers. The objective of this study was to evaluate the clinical significance of Cav-1 expression in invasive epithelial ovarian cancer (OvCa). Epithelial and stromal Cav-1 expression were quantified in serous OvCa and benign ovarian tissue in two, independent cohorts\u2013one quantified expression using immunohistochemistry (IHC) and the other using multiplex immunofluorescence (IF) with digital image analysis designed to target CAF-specific expression. Cav-1 expression was significantly downregulated in OvCa stroma compared to non-neoplastic stroma using both the IHC (p = 0.002) and IF (p = 1.8x10\n                    <jats:sup>-13<\/jats:sup>\n                    ) assays. OvCa stroma showed Cav-1 downregulation compared to tumor epithelium with IHC (p = 1.2x10\n                    <jats:sup>-24<\/jats:sup>\n                    ). Conversely, Cav-1 expression was higher in OvCa stroma compared to tumor epithelium with IF (p = 0.002). There was moderate correlation between IHC and IF methods for stromal Cav-1 expression (\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>2<\/jats:italic>\n                    <\/jats:sup>\n                    = 0.69, p = 0.006) whereas there was no correlation for epithelial expression (\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>2<\/jats:italic>\n                    <\/jats:sup>\n                    = 0.006, p = 0.98). Irrespective of the staining assay, neither response to therapy or overall survival correlated with the expression level of Cav-1 in the stroma or tumor epithelium. Our findings demonstrate a loss of stromal Cav-1 expression in ovarian serous carcinomas. Studies are needed to replicate these findings and explore therapeutic implications, particularly for immunotherapy response.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0256615","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T15:03:02Z","timestamp":1637679782000},"page":"e0256615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes"],"prefix":"10.1371","volume":"16","author":[{"given":"Daryoush","family":"Saeed-Vafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Marchion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeshir","family":"Hakam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Wenham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin M.","family":"Apte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dung-Tsa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Magliocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan M.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-257X","authenticated-orcid":true,"given":"Brett M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4726-9264","authenticated-orcid":true,"given":"Jennifer B.","family":"Permuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"pone.0256615.ref001","unstructured":"American Cancer Society. Cancer Facts & Figures 2018 2018 [cited 2018]. Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2018\/cancer-facts-and-figures-2018.pdf."},{"issue":"5","key":"pone.0256615.ref002","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"IG Schauer","year":"2011","journal-title":"Neoplasia (New York, NY)."},{"issue":"1","key":"pone.0256615.ref003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/IGC.0b013e3181bda1cb","article-title":"Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma","volume":"20","author":"A Labiche","year":"2010","journal-title":"International journal of gynecological cancer: official journal of the International Gynecological Cancer Society"},{"issue":"3","key":"pone.0256615.ref004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/gcc.21916","article-title":"EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy","volume":"51","author":"F Kataoka","year":"2012","journal-title":"Genes, chromosomes & cancer"},{"issue":"2","key":"pone.0256615.ref005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3892\/ijo.2012.1475","article-title":"Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells","volume":"41","author":"D Lai","year":"2012","journal-title":"International journal of oncology"},{"issue":"1","key":"pone.0256615.ref006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion","volume":"303","author":"Y Zhang","year":"2011","journal-title":"Cancer letters"},{"issue":"17","key":"pone.0256615.ref007","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1158\/1078-0432.CCR-11-0432","article-title":"Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.","volume":"17","author":"AD Steg","year":"2011","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research."},{"issue":"2","key":"pone.0256615.ref008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1309\/U40R-1BN4-6KJ3-BDG3","article-title":"Caveolin-1 expression in ovarian carcinoma is MDR1 independent","volume":"117","author":"B Davidson","year":"2002","journal-title":"American journal of clinical pathology"},{"issue":"2","key":"pone.0256615.ref009","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/gyno.2001.6156","article-title":"Caveolin-1 expression in advanced-stage ovarian carcinoma\u2014a clinicopathologic study","volume":"81","author":"B Davidson","year":"2001","journal-title":"Gynecologic oncology"},{"issue":"10","key":"pone.0256615.ref010","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.4161\/cc.24497","article-title":"Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide","volume":"12","author":"K Quann","year":"2013","journal-title":"Cell cycle (Georgetown, Tex)."},{"issue":"5","key":"pone.0256615.ref011","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)63010-6","article-title":"Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene","volume":"159","author":"K Wiechen","year":"2001","journal-title":"The American journal of pathology"},{"issue":"6","key":"pone.0256615.ref012","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers","volume":"174","author":"AK Witkiewicz","year":"2009","journal-title":"The American journal of pathology"},{"issue":"15","key":"pone.0256615.ref013","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.4161\/cc.8.15.9116","article-title":"An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation","volume":"8","author":"D Di Vizio","year":"2009","journal-title":"Cell cycle (Georgetown, Tex)."},{"issue":"6","key":"pone.0256615.ref014","doi-asserted-by":"crossref","first-page":"e97239","DOI":"10.1371\/journal.pone.0097239","article-title":"Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer","volume":"9","author":"T Shan","year":"2014","journal-title":"PloS one"},{"issue":"10","key":"pone.0256615.ref015","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.bjc.6601359","article-title":"Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma","volume":"89","author":"L Campbell","year":"2003","journal-title":"British journal of cancer"},{"issue":"1","key":"pone.0256615.ref016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.4217","article-title":"Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression","volume":"231","author":"G Ayala","year":"2013","journal-title":"J Pathol"},{"issue":"10","key":"pone.0256615.ref017","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.4161\/cc.9.10.11601","article-title":"The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts","volume":"9","author":"G Bonuccelli","year":"2010","journal-title":"Cell cycle (Georgetown, Tex)."},{"issue":"5","key":"pone.0256615.ref018","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ejca.2010.10.018","article-title":"Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma","volume":"47","author":"S Rossi","year":"2011","journal-title":"European journal of cancer (Oxford, England: 1990)."},{"issue":"4","key":"pone.0256615.ref019","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.4034","article-title":"Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts","volume":"227","author":"SA Simpkins","year":"2012","journal-title":"The Journal of pathology"},{"issue":"2","key":"pone.0256615.ref020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0194599813512781","article-title":"Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status","volume":"150","author":"S Paskas","year":"2014","journal-title":"Otolaryngology\u2014head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery"},{"issue":"7","key":"pone.0256615.ref021","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ar.21147","article-title":"Hepatocyte Growth Factor Induces Invasion and Migration of Ovarian Cancer Cells by Decreasing the Expression of E-Cadherin, beta-Catenin, and Caveolin-1","volume":"293","author":"J Hu","year":"2010","journal-title":"Anat Rec"},{"issue":"47","key":"pone.0256615.ref022","doi-asserted-by":"crossref","first-page":"40900","DOI":"10.1074\/jbc.M111.286146","article-title":"A Glycosphingolipid\/Caveolin-1 Signaling Complex Inhibits Motility of Human Ovarian Carcinoma Cells","volume":"286","author":"A Prinetti","year":"2011","journal-title":"J Biol Chem"},{"issue":"10","key":"pone.0256615.ref023","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.onc.1207991","article-title":"Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling","volume":"24","author":"V Syed","year":"2005","journal-title":"Oncogene"},{"issue":"41","key":"pone.0256615.ref024","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1038\/sj.onc.1203839","article-title":"Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression","volume":"19","author":"M Bagnoli","year":"2000","journal-title":"Oncogene"},{"issue":"5","key":"pone.0256615.ref025","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)63010-6","article-title":"Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene","volume":"159","author":"WC Kai","year":"2001","journal-title":"American Journal of Pathology"},{"issue":"6","key":"pone.0256615.ref026","doi-asserted-by":"crossref","first-page":"424","DOI":"10.17772\/gp\/2398","article-title":"Expression of caveolin-1 in peritumoral stroma is associated with histological grade in ovarian serous tumors.","volume":"86","author":"S Sayhan","year":"2015","journal-title":"Ginekologia polska."},{"key":"pone.0256615.ref027","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-011811-120902","article-title":"Digital imaging in pathology: whole-slide imaging and beyond.","volume":"8","author":"F Ghaznavi","year":"2013","journal-title":"Annual review of pathology."},{"key":"pone.0256615.ref028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of ovarian cancer","volume":"472","author":"J Permuth-Wey","year":"2009","journal-title":"Methods in molecular biology (Clifton, NJ)."},{"key":"pone.0256615.ref029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-7-42","article-title":"Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.","volume":"7","author":"AE Rizzardi","year":"2012","journal-title":"Diagnostic pathology."},{"issue":"8","key":"pone.0256615.ref030","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","article-title":"Hallmarks of cancer: interactions with the tumor stroma","volume":"316","author":"K Pietras","year":"2010","journal-title":"Experimental cell research"},{"issue":"2","key":"pone.0256615.ref031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/path.2803","article-title":"Jekyll and Hyde: the role of the microenvironment on the progression of cancer","volume":"223","author":"M Allen","year":"2011","journal-title":"The Journal of pathology"},{"key":"pone.0256615.ref032","first-page":"295","volume-title":"Aqua technology and molecular pathology","author":"M Gustavson","year":"2009"},{"issue":"16","key":"pone.0256615.ref033","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4161\/cc.9.16.12553","article-title":"Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells","volume":"9","author":"UE Martinez-Outschoorn","year":"2010","journal-title":"Cell cycle (Georgetown, Tex)."},{"issue":"19","key":"pone.0256615.ref034","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","article-title":"Cancer-Associated Fibroblasts Affect Intratumoral CD8(+) and FoxP3(+) T Cells Via IL6 in the Tumor Microenvironment.","volume":"24","author":"T Kato","year":"2018","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research."},{"issue":"1","key":"pone.0256615.ref035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-2215-5-19","article-title":"Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures","volume":"5","author":"DK Chan","year":"2012","journal-title":"Journal of ovarian research"},{"issue":"5","key":"pone.0256615.ref036","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo","volume":"13","author":"R Rattan","year":"2011","journal-title":"Neoplasia (New York, NY)."},{"issue":"19","key":"pone.0256615.ref037","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1158\/1078-0432.CCR-12-0507","article-title":"A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer.","volume":"18","author":"AA Secord","year":"2012","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research."},{"issue":"1","key":"pone.0256615.ref038","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ygyno.2010.11.017","article-title":"Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells.","volume":"121","author":"D Teoh","year":"2011","journal-title":"Gynecologic oncology"},{"issue":"4","key":"pone.0256615.ref039","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajog.2009.10.883","article-title":"Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells","volume":"202","author":"P Loar","year":"2010","journal-title":"American journal of obstetrics and gynecology"},{"key":"pone.0256615.ref040","first-page":"723","article-title":"Generating Region of Interests for Invasive Breast Cancer in Histopathological Whole-Slide-Image.","volume":"2020","author":"SM Patil","year":"2020","journal-title":"Proc COMPSAC"},{"issue":"22","key":"pone.0256615.ref041","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.4161\/cc.22226","article-title":"Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFkappaB activation in the tumor stroma","volume":"11","author":"UE Martinez-Outschoorn","year":"2012","journal-title":"Cell cycle (Georgetown, Tex)."},{"key":"pone.0256615.ref042","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00257","article-title":"Time and Circumstances: Cancer Cell Metabolism at various Stages of Disease Progression.","volume":"6","author":"GF Weber","year":"2016","journal-title":"Front Oncol"},{"issue":"6","key":"pone.0256615.ref043","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jjco\/hyab040","article-title":"Histopathological atlas of desmoplastic reaction characterization in colorectal cancer","volume":"51","author":"H Ueno","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"pone.0256615.ref044","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.MP.0000051582.75890.2D","article-title":"Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan","volume":"16","author":"M Wernicke","year":"2003","journal-title":"Mod Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T15:03:50Z","timestamp":1637679830000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256615"}},"subtitle":[],"editor":[{"given":"Yihong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0256615","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.18.456818","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}